Several research groups have focused on the mechanism that underlying the features of tumorigenesis and cancer cell survival in the setting of SDH mutations
LV volumes and ejection fraction were not different between PCD patients, carriers and healthy subjects
Researchers have been able to show that GLP-1 diminishes post-meal glucose excursions in type-1 diabetes patients and GLP-1 increases glucose disposal in an insulin independent manner
External resources The Lancet: Effects of retatrutide on body composition in people with type 2 diabetes New England Journal of Medicine: Triple-Hormone-Receptor Agonist Retatrutide for Obesity PMC: Saving muscle while losing weight on GLP-1 related drugs In case I do not see you, good afternoon, good evening, and good night
Analysts expect this wave to expand the addressable market dramatically, as millions of patients priced out of branded GLP-1s finally gain access
The studies we have asked: Does 2.4 mg work better than 1.0 mg? Not: Whats the lowest dose that provides benefit? The Weight Loss Confound: The prosecution says effects disappear when you control for weight loss